Rosette morphology in zona glomerulosa formation and function.

Adherent junction Adrenal cortex Aldosterone Calcium signaling Cyp11b2 Epithelial remodeling FGFR2 GCaMP3 Morphogenesis Optopatch Rosette Zona fasciculata Zona glomerulosa Zonal transdifferentiation

Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 28 01 2021
revised: 29 03 2021
accepted: 13 04 2021
pubmed: 24 4 2021
medline: 15 12 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

How morphology informs function is a fundamental biological question. Here, we review the morphological features of the adrenal zona glomerulosa (zG), highlighting recent cellular and molecular discoveries that govern its formation. The zG consists of glomeruli enwrapped in a Laminin-β1-enriched basement membrane (BM). Within each glomerulus, zG cells are organized as rosettes, a multicellular structure widely used throughout development to mediate epithelial remodeling, but not often found in healthy adult tissues. Rosettes arise by constriction at a common cellular contact point mediated/facilitated by adherens junctions (AJs). In mice, small, dispersed AJs first appear postnatally and enrich along the entire cell-cell contact around 10 days after birth. Subsequently, these AJ-rich contacts contract, allowing rosettes to form. Concurrently, flat sheet-like domains in the nascent zG, undergo invagination and folding, gradually giving rise to the compact round glomeruli that comprise the adult zG. How these structures impact adrenal function is discussed.

Identifiants

pubmed: 33891993
pii: S0303-7207(21)00131-3
doi: 10.1016/j.mce.2021.111287
pmc: PMC8159910
mid: NIHMS1696695
pii:
doi:

Substances chimiques

Laminin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111287

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK123694
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL036977
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138241
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Philos Trans R Soc Lond B Biol Sci. 2020 Oct 12;375(1809):20190552
pubmed: 32829682
Mol Cell Endocrinol. 2013 May 22;371(1-2):182-8
pubmed: 23376610
Development. 2008 Apr;135(8):1493-502
pubmed: 18339671
Development. 2008 Aug;135(15):2593-602
pubmed: 18599507
Development. 2014 Jul;141(13):2549-58
pubmed: 24961796
Mol Biol Cell. 2012 Jun;23(11):2131-42
pubmed: 22493320
Nat Rev Endocrinol. 2015 Jan;11(1):14-28
pubmed: 25287283
Annu Rev Physiol. 2021 Feb 10;83:451-475
pubmed: 33176563
Development. 2010 Dec;137(24):4295-305
pubmed: 21098570
Genes Dev. 2019 Feb 1;33(3-4):209-220
pubmed: 30692207
Development. 2012 Dec;139(24):4571-81
pubmed: 23136387
Mol Cell Endocrinol. 2017 Feb 5;441:146-155
pubmed: 27619404
Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66
pubmed: 25772309
Cell Rep. 2020 Apr 21;31(3):107524
pubmed: 32320669
Dev Cell. 2018 Jul 16;46(2):173-188.e3
pubmed: 30016620
Cell. 2012 May 25;149(5):1084-97
pubmed: 22632972
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16558-63
pubmed: 17940049
Nat Rev Mol Cell Biol. 2014 Jun;15(6):397-410
pubmed: 24824068
Dev Cell. 2006 Oct;11(4):459-70
pubmed: 17011486
Phys Rev E Stat Nonlin Soft Matter Phys. 2009 May;79(5 Pt 2):056104
pubmed: 19518518
Front Endocrinol (Lausanne). 2015 Mar 05;6:27
pubmed: 25798129
Curr Top Dev Biol. 2013;106:239-312
pubmed: 24290352
J Neurosci. 2016 Oct 26;36(43):11059-11073
pubmed: 27798186
Am J Anat. 1979 Dec;156(4):453-503
pubmed: 525624
J Clin Invest. 2012 Jun;122(6):2046-53
pubmed: 22546854
Mol Cell Endocrinol. 2015 Sep 15;413:168-77
pubmed: 26141512
Genes Dev. 2016 Jun 15;30(12):1389-94
pubmed: 27313319
Cell Stem Cell. 2019 Aug 1;25(2):290-296.e2
pubmed: 31104943
Nat Commun. 2020 Apr 3;11(1):1680
pubmed: 32245949
Nat Commun. 2016 Sep 14;7:12751
pubmed: 27624192
Dev Cell. 2013 Sep 30;26(6):666-673
pubmed: 24035414
Hum Mol Genet. 2010 Apr 15;19(8):1561-76
pubmed: 20106872
Nat Genet. 2012 Dec;44(12):1382-7
pubmed: 23143599
Nat Commun. 2020 Apr 3;11(1):1679
pubmed: 32245948
Hum Mol Genet. 2014 Feb 15;23(4):889-905
pubmed: 24087794

Auteurs

Sining Leng (S)

Division of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA. Electronic address: sining.leng@gmail.com.

Diana L Carlone (DL)

Division of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA. Electronic address: diana.carlone@childrens.harvard.edu.

Nick A Guagliardo (NA)

Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: Nag4g@virginia.edu.

Paula Q Barrett (PQ)

Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: Pqb4b@virginia.edu.

David T Breault (DT)

Division of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA. Electronic address: david.breault@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH